» Articles » PMID: 38667053

The Epidemiology, Management and Therapeutic Outcomes of Subdural Empyema in Neonates with Acute Bacterial Meningitis

Overview
Specialty Pharmacology
Date 2024 Apr 26
PMID 38667053
Authors
Affiliations
Soon will be listed here.
Abstract

Subdural empyema is one of the more serious complications of bacterial meningitis and therapeutic challenges to clinicians. We aimed to evaluate the clinical characteristics, treatment, and outcome of subdural empyema in neonates with bacterial meningitis. A retrospective cohort study was conducted in two medical centers in Taiwan that enrolled all cases of neonates with subdural empyema after bacterial meningitis between 2003 and 2020. Subdural empyema was diagnosed in 27 of 153 (17.6%) neonates with acute bacterial meningitis compared with cases of meningitis without subdural empyema. The demographics and pathogen distributions were comparable between the study group and the controls, but neonates with subdural empyema were significantly more likely to have clinical manifestations of fever (85.2%) and seizure (81.5%) (both values < 0.05). The cerebrospinal fluid results of neonates with subdural empyema showed significantly higher white blood cell counts, lower glucose levels and higher protein levels ( = 0.011, 0.003 and 0.006, respectively). Neonates with subdural empyema had a significantly higher rate of neurological complications, especially subdural effusions and periventricular leukomalacia. Although the final mortality rate was not increased in neonates with subdural empyema when compared with the controls, they were often treated much longer and had a high rate of long-term neurological sequelae. Subdural empyema is not uncommon in neonates with acute bacterial meningitis and was associated with a high risk of neurological complications, although it does not significantly increase the final mortality rate. Close monitoring of the occurrence of subdural empyema is required, and appropriate long-term antibiotic treatment after surgical intervention may lead to optimized outcomes.

References
1.
Jim K, Brouwer M, van der Ende A, van de Beek D . Subdural empyema in bacterial meningitis. Neurology. 2012; 79(21):2133-9. DOI: 10.1212/WNL.0b013e3182752d0e. View

2.
Kralik S, Kukreja M, Paldino M, Desai N, Vallejo J . Comparison of CSF and MRI Findings among Neonates and Infants with or Group B Streptococcal Meningitis. AJNR Am J Neuroradiol. 2019; 40(8):1413-1417. PMC: 7048479. DOI: 10.3174/ajnr.A6134. View

3.
Tavares T, Pinho L, Bonifacio Andrade E . Group B Streptococcal Neonatal Meningitis. Clin Microbiol Rev. 2022; 35(2):e0007921. PMC: 8849199. DOI: 10.1128/cmr.00079-21. View

4.
Lin C, Chu S, Wang H, Yang P, Huang H, Chiang M . Complicated Sepsis with/without Meningitis in Young Infants and Newborns: The Clinical and Molecular Characteristics and Outcomes. Microorganisms. 2021; 9(10). PMC: 8540989. DOI: 10.3390/microorganisms9102094. View

5.
Erickson T, Munoz F, Troisi C, Nolan M, Hasbun R, Brown E . The Epidemiology of Meningitis in Infants under 90 Days of Age in a Large Pediatric Hospital. Microorganisms. 2021; 9(3). PMC: 7999219. DOI: 10.3390/microorganisms9030526. View